Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EPTIFIBATIDE vs ERDAFITINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EPTIFIBATIDE vs ERDAFITINIB: Safety Overview

Metric EPTIFIBATIDE ERDAFITINIB
Total FAERS Reports 462 1,106
Deaths Reported 57 315
Death Rate 12.3% 28.5%
Hospitalizations 143 226
Average Patient Age 57.2 yrs 66.6 yrs
% Female Patients 30.9% 37.9%
FDA Approval Date Apr 18, 2017 Apr 12, 2019
Manufacturer Slate Run Pharmaceuticals, LLC Janssen Products LP
Route INTRAVENOUS ORAL
Marketing Status Discontinued Prescription